Pascal Morel

5.5k total citations
148 papers, 2.5k citations indexed

About

Pascal Morel is a scholar working on Hematology, Management of Technology and Innovation and Epidemiology. According to data from OpenAlex, Pascal Morel has authored 148 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 34 papers in Management of Technology and Innovation and 30 papers in Epidemiology. Recurrent topics in Pascal Morel's work include Blood donation and transfusion practices (34 papers), Blood transfusion and management (23 papers) and Blood groups and transfusion (18 papers). Pascal Morel is often cited by papers focused on Blood donation and transfusion practices (34 papers), Blood transfusion and management (23 papers) and Blood groups and transfusion (18 papers). Pascal Morel collaborates with scholars based in France, Switzerland and United States. Pascal Morel's co-authors include Pierre Fenaux, Pierre Gallian, JL Laï, Pierre Tiberghien, J L Laï, F Bauters, Xavier de Lamballerie, Syria Laperche, Patrick Hervé and Danielle Rebibo and has published in prestigious journals such as Blood, PLoS ONE and Hepatology.

In The Last Decade

Pascal Morel

137 papers receiving 2.4k citations

Peers

Countries citing papers authored by Pascal Morel

Since Specialization

Citations

This map shows the geographic impact of Pascal Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Morel more than expected).

Fields of papers citing papers by Pascal Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Morel. The network helps show where Pascal Morel may publish in the future.

Co-authorship network of co-authors of Pascal Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Morel. A scholar is included among the top collaborators of Pascal Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Morel. Pascal Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France 2022 ·Vox Sanguinis ·Josiane Pillonel, (unknown), Cécile Sommen, Julie Figoni, (unknown), (unknown), Pascale Richard, Pascal Morel, Pierre Gallian, Syria Laperche	3
2	Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France 2022 ·Transfusion ·(unknown), Pierre Gallian, (unknown), (unknown), Valérie Barlet, (unknown), (unknown), (unknown), Pierre Cappy, Josiane Pillonel, Syria Laperche, Pascal Morel	3
3	Measles and rubella seroprevalence in a population of young adult blood donors, France 2013 2019 ·Epidemiology and Infection ·Denise Antona, Pascal Morel, (unknown), Laure Fonteneau, Julia Dina, Christelle Vauloup‐Fellous, Luís Andrés Gimeno-Feliú, Armelle Degeorges, Pierre Gallian, D Lévy-Brühl	9
4	Validation of an automated blood culture system for sterility testing of cell therapy products 2013 ·Cytotherapy ·Didier Hocquet, Marlène Sauget, Sandrine Roussel, (unknown), Fabienne Pouthier, Pascal Morel, Houssein Gbaguidi‐Haore, Xavier Bertrand, Frédéric Grenouillet	16
5	Maîtrise du risque bactérien transfusionnel en France en 2013 2013 ·Transfusion Clinique et Biologique ·Pascal Morel, M Deschaseaux, Xavier Bertrand, (unknown), (unknown), Laurent Bardiaux	12
6	Localisation cutanée et épidurale d’une histiocytose de Rosai-Dorfman 2007 ·Annales de Dermatologie et de Vénéréologie ·(unknown), J. Wendling, E. Bourrat, (unknown), Delphine Kérob, F. Cordoliani, Anne Janin, Pascal Morel, (unknown)	4
7	Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? 2005 ·Transfusion ·Syria Laperche, (unknown), Pascal Morel, Marianne Asso‐Bonnet, Nadine Le Marrec, A Girault, Annabelle Servant‐Delmas, Françoise Bouchardeau, Marie Deschaseaux, Y. Piquet	45
8	Vers la détection des bactéries dans les PSL 2005 ·Transfusion Clinique et Biologique ·Pascal Morel	4
9	Low‐dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis 2005 ·Alimentary Pharmacology & Therapeutics ·Philippe de Saussure, Claudio Soravia, Pascal Morel, Antoine Hadengue	14
10	De la détection bactérienne à l'inactivation des pathogènes 2005 ·Transfusion Clinique et Biologique ·Pascal Morel, M Deschaseaux, (unknown), Laurent Bardiaux, (unknown), Fabienne Pouthier	3
11	Contamination of Trypan Blue With Burkholderia cepacia in a Cornea Bank 2003 ·Infection Control and Hospital Epidemiology ·Pascal Morel, (unknown), D. Talon, Xavier Bertrand	4
12	HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation 2003 ·Transfusion ·Syria Laperche, Pascal Morel, Marie Deschaseaux, Françoise Bouchardeau, (unknown), Nicolas Guillaume, Philippe Rouger, Jean‐Jacques Lefrère	22
13	Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998 2002 ·Transfusion ·Georges Andreu, Pascal Morel, François Forestier, J Debeir, Danielle Rebibo, G Janvier, Patrick Hervé	214
14	[Blood transfusion surveillance: organization and results]. 2001 ·PubMed ·Danielle Rebibo, Pascal Morel, (unknown), Patrick Hervé	1
15	[What present strategies are helpful in improving transfusion safety in France?]. 1999 ·PubMed ·P Hervé, V. Lapierre, Pascal Morel, Pierre Tiberghien	2
16	Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24 1999 ·Anne Couroucé, Françis Barin, S. Chamaret, Fabienne Durand, M.H. Elghouzzi, Syria Laperche, J.M. Lemaire, Patrick Maisonneuve, M. Maniez, P. Moncharmont, Pascal Morel, Fabrice Morin, (unknown), Lina Noël, (unknown), Josiane Pillonel, Y. Piquet, C. Rouzioux, C. Saura, (unknown)	12
17	[Hepatic lesions after effective external cardiac massage--an iatrogenic complication not to be overlooked]. 1998 ·PubMed ·(unknown), (unknown), Marjorie J. Robertson, Pascal Morel	0
18	Internalization and degradation of anti-CD4 monoclonal antibodies bound to human peripheral blood lymphocytes 1993 ·Molecular Immunology ·Pascal Morel, C. Vincent, John Wijdenes, Jean‐Pierre Revillard	11
19	Down-regulation of lymphocyte CD4 antigen expression by administration of anti-CD4 monoclonal antibody 1992 ·Clinical Immunology and Immunopathology ·Pascal Morel, Jean‐François Nicolas, John Wijdenes, J. P. Révillard	15
20	Relation between flow-pressure-diameter studies in experimental stenosis of rabbit and human small bowel. 1990 ·Gut ·Pascal Morel, J Alexander-Williams, A Rohner	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact